USPTO Examiner PAGE BRENT T - Art Unit 1663

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18688976COMPOSITIONS AND METHODS FOR CONFERRING RESISTANCE TO GEMINIVIRUSMarch 2024January 2025Allow1011NoNo
18415374SOYBEAN CULTIVAR 01150116January 2024March 2025Abandon1410NoNo
18405535BRASSICA OLERACEA PLANTS WITH IMPROVED NUTRITIONAL VALUEJanuary 2024March 2025Allow1420NoNo
18402366SOYBEAN CULTIVAR 04120326January 2024March 2025Abandon1410NoNo
18402406SOYBEAN CULTIVAR 00180217January 2024March 2025Abandon1410NoNo
18395201SOYBEAN CULTIVAR 05170307December 2023February 2025Abandon1410NoNo
18530946MODULATION OF TRANSGENE EXPRESSION IN PLANTSDecember 2023June 2025Allow1920NoNo
18524366GH61 VARIANTS AND POLYNUCLEOTIDES ENCODING SAMENovember 2023February 2025Allow1410NoNo
18493372TOLCNDV RESISTANT MELON PLANTSOctober 2023December 2024Allow1310NoNo
18369615METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIRSeptember 2023November 2024Abandon1410NoNo
18456080RECOMBINANT MICELLE AND METHOD OF IN VIVO ASSEMBLYAugust 2023December 2024Allow1630NoNo
18232077SOYBEAN CULTIVAR 94260428August 2023September 2024Abandon1310NoNo
18352428GENETIC BASIS FOR PYTHIUM RESISTANCEJuly 2023September 2024Allow1410NoNo
18220710SOYBEAN VARIETY '2987416'July 2023September 2024Allow1410NoNo
18216535SOYBEAN VARIETY '20012048'June 2023September 2024Allow1510NoNo
18216492SOYBEAN VARIETY '20013989'June 2023September 2024Allow1510NoNo
18329645SOYBEAN CULTIVAR EE1660299June 2023August 2024Allow1410NoNo
18181704METHODS AND COMPOSITIONS FOR IDENTIFYING AND ENRICHING FOR CELLS COMPRISING SITE SPECIFIC GENOMIC MODIFICATIONSMarch 2023October 2023Allow701NoNo
18177951COMPOSITIONS AND METHODS FOR MODIFYING GENOMESMarch 2023September 2024Allow1911YesNo
18152718MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSIONJanuary 2023February 2025Allow2520YesNo
18152722MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSIONJanuary 2023August 2024Allow1920NoNo
18093733SOYBEAN CULTIVAR 05170307January 2023January 2024Abandon1210NoNo
18093735SOYBEAN CULTIVAR 00180217January 2023January 2024Abandon1210NoNo
18093725SOYBEAN CULTIVAR 01150116January 2023February 2024Abandon1310NoNo
18093731SOYBEAN CULTIVAR 04120326January 2023January 2024Abandon1210NoNo
18149059WHEAT CULTIVAR 01095167December 2022June 2025Allow3010NoNo
18084433Plant thermo-sensitive male sterile mutant tms15 and uses thereofDecember 2022December 2024Allow2410NoNo
18066315WHEAT VARIETY 6PQYM93BDecember 2022February 2025Allow2610NoNo
18066384WHEAT VARIETY 6PMZM22BDecember 2022February 2025Allow2610NoNo
18066323WHEAT VARIETY 6PNHF40BDecember 2022February 2025Allow2620NoNo
18079576SOYBEAN VARIETY 01083697December 2022January 2024Abandon1310NoNo
18079566SOYBEAN VARIETY 01083698December 2022December 2023Abandon1210NoNo
18074633SOYBEAN CULTIVARDecember 2022March 2024Allow1510NoNo
18074089Plants and Seeds of Hybrid Corn Variety CH010407December 2022February 2025Allow2710NoNo
18072573Plants and Seeds of Corn Variety CV554903November 2022February 2025Allow2710NoNo
18072640Plants and Seeds of Hybrid Corn Variety CH010434November 2022February 2025Allow2710NoNo
18071186MELON VARIETY NUN 71560 MEMNovember 2022February 2025Allow2710NoNo
18071252MELON VARIETY NUN 71510 MEMNovember 2022February 2025Allow2710NoNo
17994351Plants and Seeds of Corn Variety CV868880November 2022February 2025Allow2710NoNo
17994327Plants and Seeds of Hybrid Corn Variety CH010364November 2022February 2025Allow2710NoNo
17994299Plants and Seeds of Hybrid Corn Variety CH010400November 2022April 2025Allow2910NoNo
17993964SOYBEAN VARIETY 01098296November 2022April 2025Allow2910NoNo
17993934SOYBEAN VARIETY 01098249November 2022April 2025Allow2910NoNo
17992461Plants and Seeds of Hybrid Corn Variety CH010388November 2022March 2025Allow2810NoNo
17992614SOYBEAN VARIETY 01098202November 2022April 2025Allow2910NoNo
17992417SOYBEAN VARIETY 01098164November 2022April 2025Allow2910NoNo
17990888SOYBEAN VARIETY 01094810November 2022May 2025Allow3010NoNo
17990718SOYBEAN VARIETY 01094793November 2022April 2025Allow2910NoNo
17987468Plants and Seeds of Hybrid Corn Variety CH010381November 2022December 2024Allow2510NoNo
17987025Plants and Seeds of Corn Variety CV874402November 2022February 2025Allow2710NoNo
17984490VARIETY CORN LINE ADAQ3615November 2022June 2025Allow3110NoNo
17984938QTLS FOR POWDERY MILDEW RESISTANCE IN MELONNovember 2022December 2023Allow1310NoNo
17998341BREEDING METHOD AND USE OF BLUE-GRAINED TWO-LINE HYBRID WHEAT SYSTEMNovember 2022June 2025Allow3111NoNo
17981737VARIETY CORN LINE HAF4600November 2022January 2025Allow2710NoNo
18050259GENERATION OF HAPOLOID PLANTS BASED ON KNL2October 2022March 2024Abandon1710NoNo
18046988TRANSGENIC MAIZE PLANT EXHIBITING INCREASED YIELD AND DROUGHT TOLERANCEOctober 2022February 2024Allow1610NoNo
17965952LETTUCE CULTIVAR ADEMPACKOctober 2022August 2024Allow2210NoNo
17936630TARGETED GENE DEMETHYLATION IN PLANTSSeptember 2022January 2024Abandon1510NoNo
17933096Cannabis Hybrid Varieties and Parent LinesSeptember 2022June 2025Abandon3311NoNo
17932553CANOLA INBRED 4PLFG02RSeptember 2022July 2024Allow2210NoNo
17932540CANOLA INBRED 4PNRM27RSeptember 2022July 2024Allow2210NoNo
17932462CANOLA HYBRID 19MM0052NSeptember 2022February 2025Abandon2910NoNo
17931981TRITICALE CULTIVAR APT1425621September 2022January 2025Allow2910NoNo
17931436MODULATION OF TRANSGENE EXPRESSION IN PLANTSSeptember 2022September 2023Allow1210NoNo
17930907TOLERANCE IN PLANTS OF SOLANUM LYCOPERSICUM TO THE TOBAMOVIRUS TOMATO BROWN RUGOSE FRUIT VIRUS (TBRFV)September 2022October 2023Allow1310NoNo
17900255SOYBEAN CULTIVAR 15050102August 2022July 2024Allow2310NoNo
17900152SOYBEAN CULTIVAR 19320106August 2022July 2024Allow2310NoNo
17899699ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, CONSTRUCT AND PLANTS COMPRISING SAME AND METHODS OF USING SAME FOR INCREASING NITROGEN USE EFFICIENCY OF PLANTSAugust 2022December 2023Abandon1510NoNo
17822615METHODS FOR PRODUCING CORN PLANTS WITH DOWNY MILDEW RESISTANCE AND COMPOSITIONS THEREOFAugust 2022April 2024Allow2000NoNo
17820965GARDEN BEAN VARIETY 'PELICAN'August 2022November 2024Allow2720NoNo
17800388METHOD FOR SELECTING SEED SIZE IN WATERMELON AND GENERATING MODIFICATIONS IN THE TOMATO-SEED SIZE GENEAugust 2022February 2025Allow3020NoNo
17817899CRISPR-CAS SYSTEM FOR AN ALGAL HOST CELLAugust 2022December 2023Abandon1710NoNo
17859053PLANT WITH ALTERED CONTENT OF STEROIDAL ALKALOIDSJuly 2022November 2023Allow1710NoNo
17808611MAIZE HYBRID X13R107June 2022December 2024Allow3010NoNo
17849401SPOTTED WATERMELON PLANTSJune 2022June 2025Allow3611NoNo
17807521MAIZE INBRED 1PMTR32June 2022February 2025Allow3220NoNo
17842562HYBRID SWEET CORN PLANT NAMED SUMMER CELEBRATIONJune 2022May 2024Allow2310NoNo
17834755SOYBEAN VARIETIES '2806910', '3446748', '3447684', '2808155', '3448140', '3448145', '3457104', '2808633', AND '1446640'June 2022January 2024Abandon2011NoNo
17826021RECOMBINANT MICELLE AND METHOD OF IN VIVO ASSEMBLYMay 2022May 2025Allow3511NoNo
17775556PUCCINIA RESISTANCE GENEMay 2022December 2024Allow3120NoNo
17717000RECOMBINANT MICELLE AND METHOD OF IN VIVO ASSEMBLYApril 2022June 2023Allow1421YesNo
17715094ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING NITROGEN USE EFFICIENCY OF PLANTSApril 2022July 2023Abandon1511NoNo
17714461GH61 Polypeptide Variants and Polynucleotides Encoding SameApril 2022August 2023Allow1710NoNo
17765746MODULATING SUGAR AND AMINO ACID CONTENT IN A PLANT (SULTR3)March 2022March 2025Allow3621NoNo
17691685BEAN VARIETY SVGZ1825March 2022April 2024Allow2510NoNo
17638446TRANSFORMED PLANTS AND METHODS FOR MAKING AND USING THE SAMEFebruary 2022December 2024Abandon3401NoNo
17427647USE OF BXL GENE OR PROTEIN ENCODED THEREBYFebruary 2022April 2024Abandon3321NoNo
17672405HYBRID PUMPKIN PLANT NAMED POPCORNFebruary 2022May 2024Allow2710NoNo
17671466METHODS AND COMPOSITIONS FOR TARGETING RNA POLYMERASES AND NON-CODING RNA BIOGENESIS TO SPECIFIC LOCIFebruary 2022March 2024Allow2530NoNo
17591720SOYBEAN VARIETYFebruary 2022June 2024Allow2920NoNo
17591746SOYBEAN VARIETYFebruary 2022March 2024Allow2510NoNo
17591785SOYBEAN VARIETY 5PKPZ42February 2022January 2025Allow3630NoNo
17591877SOYBEAN VARIETY 5PHMU91February 2022March 2024Allow2510NoNo
17591795SOYBEAN VARIETY 5PFDN83February 2022February 2025Allow3630NoNo
17591064SOYBEAN VARIETYFebruary 2022March 2024Allow2510NoNo
17590024SOYBEAN VARIETYFebruary 2022June 2024Allow2820NoNo
17585489Cotton Variety 20R914XFJanuary 2022July 2024Allow3010NoNo
17564727WHEAT CULTIVAR 01095215December 2021November 2023Allow2200NoNo
17643517SORGHUM INBRED PH3251FWDecember 2021October 2023Allow2200NoNo
17537900Methods for Producing Corn Plants with Northern Leaf Blight Resistance and Compositions ThereofNovember 2021April 2024Abandon2910NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAGE, BRENT T.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
1.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
13
Allowed After Appeal Filing
6
(46.2%)
Not Allowed After Appeal Filing
7
(53.8%)
Filing Benefit Percentile
72.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 46.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner PAGE, BRENT T - Prosecution Strategy Guide

Executive Summary

Examiner PAGE, BRENT T works in Art Unit 1663 and has examined 1,119 patent applications in our dataset. With an allowance rate of 87.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 19 months.

Allowance Patterns

Examiner PAGE, BRENT T's allowance rate of 87.9% places them in the 64% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by PAGE, BRENT T receive 1.18 office actions before reaching final disposition. This places the examiner in the 20% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PAGE, BRENT T is 19 months. This places the examiner in the 91% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +5.6% benefit to allowance rate for applications examined by PAGE, BRENT T. This interview benefit is in the 31% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 29.5% of applications are subsequently allowed. This success rate is in the 47% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 58.3% of cases where such amendments are filed. This entry rate is in the 81% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 92% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 80.0% of appeals filed. This is in the 68% percentile among all examiners. Of these withdrawals, 62.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 103.5% are granted (fully or in part). This grant rate is in the 97% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.4% of allowed cases (in the 58% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.8% of allowed cases (in the 54% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.